Established in 2008, Broadview Ventures is a venture capital firm based in Boston that focuses on accelerating the development of promising technology in cardiovascular and neurovascular diseases. The firm, supported by the Foundation Leducq, aims to bridge the funding gap in the early stages of technology ventures by providing targeted investments, licensing agreements, consortium funding arrangements, and professional support. With a mission to improve human health, Broadview Ventures seeks to invest in companies operating in various sectors across North America, Europe, and Israel, including small molecules, biologics, generic medicines, cell and gene therapies, implantable and interventional devices, remote monitoring, diagnostics, imaging, and digital technologies. By bringing innovative technologies to patients, Broadview Ventures defines success as improving human health in the areas of cardiovascular disease and stroke.